07.Market trends of Prescription Kampo in Japan

NHI price revision
  4/2000 4/2002 4/2004 4/2006 4/2008 4/2010 4/2012 4/2014 4/2016 4/2018
All pharmaceuticals -7.0% -6.3% -4.2% -6.7% -5.2% -5.75% -6.0% -5.64%* -5.57% -7.48%
All Kampo -5.6% -5.2% -3.8% -4.7% -3.6%
TSUMURA KAMPO -3.4% -3.6% -2.8% -4.2% -3.3% -4.5% -3.8% -3%* -3% approximately -3%
NHI price revision
All pharmaceuticals All Kampo TSUMURA KAMPO
4/2000 -7.0% -5.6% -3.4%
4/2002 -6.3% -5.2% -3.6%
4/2004 -4.2% -3.8% -2.8%
4/2006 -6.7% -4.7% -4.2%
4/2008 -5.2% -3.6% -3.3%
4/2010 -5.75% - -4.5%
4/2012 -6.0% - -3.8%
4/2014 -5.64%* - -3%*
4/2016 -5.57% - -3%
4/2018 -7.48% - approximately -3%

*Price revision rate excluding consumption tax.
The drug price revision rate of Tsumura including consumption tax is -0% and that of all pharmaceutical market is -2.65%.

Sales of prescription Kampo products, Tsumura's included, in FY2017 amounted to 150.9 billion yen which is 1.4% of total prescription pharmaceutical sales in the NHI Drug Price basis.

Growth rates in sales base
  3/2009 3/2010 3/2011 3/2012 3/2013 3/2014 3/2015 3/2016 3/2017 3/2018
Growth rates in sales base (compared to previous years) 6.9% 6.0% 6.5% 0.8% 10.6% 3.2% 2.4% 2.3% 1.9% 2.4%
The number of Kampo preparations (that increased in sales compared to previous year) 115 88 105 63 125 66 81 68 95 63
Growth rates in sales base
Growth rates in sales base (compared to previous years) The number of Kampo preparations (that increased in sales compared to previous year)
3/2009 6.9% 115
3/2010 6.0% 88
3/2011 6.5% 105
3/2012 0.8% 63
3/2013 10.6% 125
3/2014 3.2% 66
3/2015 2.4% 81
3/2016 2.3% 68
3/2017 3.5% 101
3/2018 2.4% 63